Global Intravenous Immunoglobulin Market [By Application (Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Hypogammaglobulinemia, Congenital AIDS, Immunodeficiency diseases, Multifocal motor neuropathy, Myasthenia Gravis, Chronic Lymphocytic Leukemia, Kawasaki disease, Guillain-Barre syndrome, and Idiopathic Thrombocytopenic Purpura (ITP)); and by Regions]: Market size & Forecast, 2018 – 2026

Table of Contents

1. Overview and Scope
   1. Research goal & scope
   2. Research assumptions
   3. Research Methodology
      1. Primary data sources
      2. Secondary data sources
   4. Key take-aways
   5. Stakeholders
2. 执行概要
   1. Market Definition
   2. Market Segmentation
3. 静脉注射Immunoglobulin Market Insights
   1. 静脉注射Immunoglobulin – Industry snapshot
   2. 静脉注射Immunoglobulin - Ecosystem analysis
   3. 静脉注射Immunoglobulin Market dynamics
      1. 静脉注射Immunoglobulin – Market Forces
         1. 静脉注射Immunoglobulin Market driver analysis
         2. 静脉注射Immunoglobulin Market restraint/challenges analysis
         3. 静脉注射Immunoglobulin Market opportunity analysis
   4. Industry analysis - Porter's five force
      1. Bargaining power of supplier
      2. Bargaining power of buyer
      3. Threat of substitute
      4. Threat of new entrant
      5. Degree of competition
   5. 静脉注射Immunoglobulin Market PEST analysis, 2017
      1. 静脉注射Immunoglobulin Industry trends
      2. Competitive Ranking Analysis
4. 静脉注射Immunoglobulin Market Size and Forecast by Application
   1. Key findings
   2. Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
      1. Global market estimates and forecasts, 2017 - 2026
   3. Hypogammaglobulinemia
      1. Global market estimates and forecasts, 2017 - 2026
   4. Congenital AIDS
      1. Global market estimates and forecasts, 2017 - 2026
   5. Immunodeficiency diseases
      1. Global market estimates and forecasts, 2017 - 2026
   6. Multifocal motor neuropathy
      1. Global market estimates and forecasts, 2017 - 2026
   7. Myasthenia Gravis
      1. Global market estimates and forecasts, 2017 - 2026
   8. Chronic Lymphocytic Leukemia
      1. Global market estimates and forecasts, 2017 - 2026
   9. Kawasaki disease
      1. Global market estimates and forecasts, 2017 - 2026
   10. Guillain-Barre syndrome
       1. Global market estimates and forecasts, 2017 - 2026
   11. Idiopathic Thrombocytopenic Purpura (ITP)
       1. Global market estimates and forecasts, 2017 - 2026
5. 静脉注射Immunoglobulin Market Size and Forecast by Regions
   1. Key findings
   2. North America
      1. 静脉注射Immunoglobulin Market by Application, 2017 - 2026
      2. U.S.
         1. 静脉注射Immunoglobulin Market by Application, 2017 - 2026
      3. Canada
         • 静脉注射Immunoglobulin Market by Application, 2017 - 2026
   3. Europe
      1. 静脉注射Immunoglobulin Market by Application, 2017 - 2026
      2. Germany
         1. 静脉注射Immunoglobulin Market by Application, 2017 - 2026
      3. UK
         1. 静脉注射Immunoglobulin Market by Application, 2017 - 2026
      4. France
         1. 静脉注射Immunoglobulin Market by Application, 2017 - 2026
      5. Italy
         1. 静脉注射Immunoglobulin Market by Application, 2017 - 2026
   4. Asia Pacific
      1. 静脉注射Immunoglobulin Market by Application, 2017 - 2026
      2. China
         • 静脉注射Immunoglobulin Market by Application, 2017 - 2026
      3. India
         1. 静脉注射Immunoglobulin Market by Application, 2017 - 2026
      4. Japan
         1. 静脉注射Immunoglobulin Market by Application, 2017 - 2026
      5. Australia
         1. 静脉注射Immunoglobulin Market by Application, 2017 - 2026
   5. Latin America
      1. 静脉注射Immunoglobulin Market by Application, 2017 - 2026
      2. Brazil
         • 静脉注射Immunoglobulin Market by Application, 2017 - 2026
      3. Mexico
         • 静脉注射Immunoglobulin Market by Application, 2017 - 2026
   6. Middle East & Africa
      1. 静脉注射Immunoglobulin Market by Application, 2017 - 2026
6. Company Profiles
   1. Baxter International Inc.
      1. Overview
      2. Financials
      3. Product Benchmarking
      4. Recent Developments
   2. CSL Ltd.
      1. Overview
      2. Financials
      3. Product Benchmarking
      4. Recent Developments
   3. Grifols S.A
      1. Overview
      2. Financials
      3. Product Benchmarking
      4. Recent Developments
   4. Octapharma AG
      1. Overview
      2. Financials
      3. Product Benchmarking
      4. Recent Developments
   5. Kedrion Biopharma Inc.
      1. Overview
      2. Financials
      3. Product Benchmarking
      4. Recent Developments
   6. LFB group
      1. Overview
      2. Financials
      3. Product Benchmarking
      4. Recent Developments
   7. Biotest AG
      1. Overview
      2. Financials
      3. Product Benchmarking
   8. China Biologics Products, Inc.
      1. Overview
      2. Financials
      3. Product Benchmarking
      4. Recent Developments
   9. BDI Pharma Inc.
      1. Overview
      2. Financials
      3. Product Benchmarking
      4. Recent Developments
   10. Bayer Healthcare
       1. Overview
       2. Financials
       3. Product Benchmarking
       4. Recent Developments